Showing results (31-40 of 286) with videos related to
Sort By:
Pageof 29
Prostate Cancer and Prostatic Diseases|June 28, 2023
Resource use in the last year of life of prostate cancer patients-A register-based analysisAndreas Banner, Sabine Wieser, Stephan MadersbacherWorld Journal of Urology|February 1, 2021
The future of urology: nonagenarians admitted to a urological wardKlaus Eredics, Theresa Luef, Stephan MadersbacherWorld Journal of Urology|August 28, 2009
Has blood volume an impact on serum PSA levels?Anton Ponholzer, Christian Temml, Stephan MadersbacherGerontology|April 4, 2019
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-ReviewStephan Madersbacher, Natalie Sampson, Zoran CuligUrology|March 18, 2003
Serum androgen levels in men: impact of health status and ageGeorg Schatzl, Stephan Madersbacher, Christian Temml, et al.BJU International|June 30, 2020
The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasiaStephan Madersbacher, Claus G Roehrborn, Matthias OelkeStem Cells (Dayton, Ohio)|June 13, 2009
Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in miceTrevor Lucas, Dietmar Abraham, Gerold Untergasser, et al.Blood|August 29, 2009
GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomibJohann Kern, Gerold Untergasser, Christoph Zenzmaier, et al.Anticancer Research|September 9, 2018
The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple MyelomaNormann Steiner, Roman Hajek, Sabina Sevcikova, et al.Lung Cancer (Amsterdam, Netherlands)|May 14, 2013
Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs)Andreas Pircher, Michael Fiegl, Gerold Untergasser, et al.Pageof 29